APTA Home Health / NAHC Webinar – Stay Alert for High-Alert Medications in Home Health: Anticoagulants and Insulin

Thursday, April 27, 2023 | 2:00- 3:00 PM EDT

 APTA Home Health is collaborating with the National Association for Home Care & Hospice (NAHC) for this nation-wide free webinar. The presenter, Melissa Bednarek, PT, DPT, PhD will define high-alert medications and focus specifically on anticoagulants and insulin.  The indications, mechanism of action, side effects and clinical implications for each medication class will be discussed.

Learning Objectives: 

  1. Define high-alert medication and list included medication classes.
  2. Describe the indications, mechanism of action, common side effects and implications for a home health patient taking anticoagulants.
  3. Describe the indications, mechanism of action, common side effects and implications for a home health patient taking insulin.

Speaker: Melissa Bednarek, PT, DPT, PhD

Price: FREE

Register

 

To Ice or Not to Ice? Icing Can Promote Muscle Regeneration After Mild Injury

Applying ice to a muscle injury is a widespread first-aid treatment, but exactly what effect does this have on the muscle regeneration and does it really help? Cumulative research by a multi-institutional Japanese research collaboration reveals that "to ice or not to ice" may depend on the degree of muscle injury.

In their latest research, the group consisting of Associate Professor Arakawa Takamitsu and Master's student Nagata Itsuki (from Kobe University's Graduate School of Health Sciences), and Assistant Professor Kawashima Masato (Kawasaki University of Medical Welfare) and colleagues have shown that applying ice to muscle damage in a small percentage of muscle fibers in rats promotes muscle regeneration. This is believed to be the first study in the world to show benefits of icing on muscle repair. In conjunction with their previous study on serious muscle injuries, it is hoped that these results can be used as a basis for more accurate guidelines on whether or not to ice such injuries.

These research findings were first reported in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology on March 6, 2023.

Research Background

"RICE treatment" is a common approach for treating the acute phase of sports injuries. This acronym stands for Rest, Ice, Compression and Elevation and it is also often used in physical education in schools and even clinical settings. There are a variety of subsequent steps that can be taken to treat the injury afterwards, yet opinions vary as to whether or not icing should be applied. However, there is a lack of evidence on the benefits of icing.

The current research team has conducted many experiments to investigate the effectiveness of icing, which led them to publish their previous findings. However, no previous animal experiments have indicated that icing promotes muscle regeneration.

In this study, the researchers focused on altering the severity of the muscle injury in the experiments. The reasoning behind this was that the majority of sports-related muscle injuries are limited; in other words less than 10% of the overall number of muscle fibers (myofibers) are damaged and necrotized. However, all animal experiments up until now had looked at more serious injuries where over 20% of the myofibers were damaged.

Thus, the team devised an animal model for mild muscle injuries, and experimented with applying ice after injury using a similar method as before.

Research Findings

After the animal was anesthetized, the muscle was exposed and clamped between forceps to induce injury. In their previous experiments, the researchers attached a 500g weight to the forceps, which induced an injury that affected 20% of the total number of fibers in the muscle. In the present study, they tried attaching a 250g weight to the forceps and demonstrated that this could be used to consistently injure 4% of the fibers (Figure 1). This is similar to the degree of injury that often occurs after sports activities such as vigorous exercise or long-distance marathon running.

Icing was carried out by placing polyethylene bags of ice on surface of the skin over three 30-minute sessions per day, with each session being 1.5 hours apart. This was continued until two days after injury for a total of nine icing sessions (i.e. immediately after injury = three sessions, one day after injury = three sessions, two days after injury = three sessions). The icing method was the same as in the previously reported study.

Observations of muscles that were regenerating in the icing group and no-icing group two weeks after injury revealed significant differences in the size of regenerating fibers in cross-sections. In other words, this demonstrated the possibility that

Macrophages are immune cells that orchestrate the reparative process of injured muscle. Pro-inflammatory macrophages accumulate in the damaged site soon after injury occurs, however they express an inducible nitric oxide synthase (iNOS), which has a disadvantageous side-effect of expanding the injury's size. The results of this team's experiments revealed that icing after mild muscle injury reduces the accumulation of iNOS-expressing pro-inflammatory macrophages. By causing this phenomenon, icing prevents the expansion of muscle injury size.

In other words, icing attenuates the recruitment of pro-inflammatory macrophages in the injury site. This was also reported in their previous study, demonstrating that this is an effect caused by icing regardless of whether the muscle injury is serious or mild. In the previous study, icing was found to delay the regeneration of muscle after a serious injury that destroyed many fibers because the pro-inflammatory macrophages were unable to sufficiently phagocytose the injured muscle. In contrast to this, the current study shows that icing has a positive effect when the muscle injury is mild because it prevents the secondary expansion of the muscle injury caused by the pro-inflammatory macrophages. It suggests that this particular effect of icing is connected to the promotion of muscle regeneration.

Read Full Article

 

CDC: Adults Need Only One Updated COVID Booster Shot, for Now

McKnight’s Home Care | By Alicia Lasek

The Centers for Disease Control and Prevention does not recommend more than one updated COVID-19 booster shot at this time for adults who have completed their primary series of vaccinations, according to guidance information updated this week.

The Food and Drug Administration in August authorized omicron-targeting vaccines made by Pfizer-BioNTech and Moderna as preferred COVID booster shots. Unlike the original monovalent vaccines, these vaccines are bivalent, protecting against both the original virus that causes COVID-19 and omicron variants BA.4 and BA.5.

In February, the CDC’s independent vaccine advisers decided that current evidence did not support more than one yearly dose of the newer, bivalent vaccines, including for older adults and other groups vulnerable to severe disease. That decision was largely based on a lack of existing data on the efficacy of multiple doses. But the CDC itself did not confirm a stance on the issue at the time.

The new CDC guidance appears a FAQ webpage directed at the public, as reported by the San Francisco Chronicle Tuesday. The CDC answers the hypothetical question of whether one should receive more than a single, updated booster by stating, “No. Currently, CDC recommends one updated COVID-19 booster dose” for everyone aged 5 years and older, and for certain younger children.

“If you have completed your updated booster dose, you are currently up to date. There is not a recommendation to get another updated booster dose,” it added in another post update March 2. In addition, the Food and Drug Administration has not authorized more than one shot.

Health officials appear to be leaning toward an emphasis on preventing severe disease as a priority over preventing infections, the Chronicle noted.

“The bottom line is that there is some waning of protection for those who got boosters more than six months ago and haven’t had an intervening infection,” Bob Wachter, MD,  chair of medicine at the University of California, San Francisco, told the news outlet. “[T]he level of protection versus severe infection continues to be fairly high, good enough that people who aren’t at super high risk are probably fine waiting until a new booster comes out in the fall.”

Clinically fragile adults, such as some elderly adults and many nursing home residents remain high risk of severe outcomes from COVID-19.  

In the meantime, the World Health Organization’s vaccination advisory group also has adjusted its COVID-19 vaccination guidance. It now recommends that countries prioritize at-risk older adults and frontline healthcare workers, among other high-risk groups — for both initial shots and boosters. With immunity levels high from infections and vaccinations, there is no longer an urgent need to prioritize healthy younger adults and children for the shots, it announced Tuesday.

 

Prior Authorization: 5 Ways CMS Changes Could Open up Future Possibilities

APTA

The U.S. Centers for Medicare & Medicaid Services has proposed new requirements that would ease some of the administrative burdens of prior authorization across a range of federal programs including Medicare Advantage, state Medicaid and Children's Health Insurance Program fee-for-service plans, Medicaid managed care plans, CHIP managed care entities, and Qualified Health Plan issuers in the federal ACA insurance exchange. Those changes, if adopted, would make life easier for providers, including PTs, almost immediately after their 2024 startup date.

But it’s broader than that. The proposed rules provide several opportunities for a more expansive conversation around prior authorization, transparency, and other aspects of administrative burden. That's yet another reason why it's crucial for APTA members and supporters to send comment letters to CMS by March 13.

Here are five ways the proposed rules — and even the comment process — could help the profession gain ground in other longer-term, big picture areas.

1. More Data = a Stronger Case (as Long as PTs Are Diligent About Appeals)

Under the proposed rules, prior authorization programs will be required to provide public data on their approval and denial rates, the rates at which they approve services after appeal, and average time frames for responding to prior authorization requests. Kate Gilliard, JD, APTA's director of health policy and payment, believes the increased transparency opens up some big opportunities.

"The new data requirements could lead to a couple of important outcomes," Gilliard said. "First, prior authorization plans could feel compelled to make better decisions, given that those decisions will become public. Second, the data will likely show policymakers just how bad things are, which could prompt more rulemaking to rein in these plans."

But, Gilliard points out, those changes aren't guaranteed — especially if providers are lax about pursuing denial appeals.

"The bottom line is, if no one appeals, then insurance companies think denials are an easy win and will do them more," Gilliard said. "Appeals would bring inappropriate practices to light under the proposed rule, and they're also an administrative burden for the insurance companies, and they don't like being weighed down with extra paperwork anymore than providers do."

2. If It Looks Like a Denial and Quacks Like a Denial …

The proposed rules' requirement for more public data has another upside: It could help to shed light on some plans' tendency to do an end run around what's effectively a denial by approving care for clearly insufficient durations and frequencies. Those micro-approvals in turn force PTs and other providers to make repeated requests for more care.

APTA says it's time for a reality check. In its comments to CMS, the association is pressing the agency to define a denial as anything less than what is requested by the clinician. APTA also is urging individual commenters to include that perspective in their own letters.

3. Let's Level the Interoperability Playing Field

CMS is proposing a new measure for clinicians to use in the Merit-based Incentive Payment System, or MIPS. Under the change, clinicians would be required to use electronic prior authorization to get MIPS credit under the Promoting Interoperability category, a category to which PTs don't have to report — yet. But CMS says that could change in 2024.

The problem is that the requirements for compliance as they now stand aren't a good fit for PTs. To meet MIPS standards, clinicians have to use certified electronic health records technology. Unfortunately, CEHRT is designed for prescribing professionals and doesn't adequately capture tasks performed by nonphysician professionals using different types of EHRs.

APTA is speaking up and urging its members to do the same in their comment letters on the proposed prior authorization rules: Tell CMS that if the agency intends to require PTs and nonphysician EHR vendors to fully participate in the interoperability parameters of MIPS, it needs to get everyone up to speed — either by lowering the CEHRT standards for nonphysicians or by providing funding for upgrades.

4. Prior Authorization Compliance Requirements Need Teeth

Under the proposed rules, prior authorization plans would be required to respond to prior authorization requests within seven calendar days — a welcome change. The problem? There's no penalty for plans that exceed the time limit.

"The only negative consequences for plans that don't meet prior authorization response deadlines is that they'll have to share that data publicly, but that's just not enough," Gilliard said. Instead, APTA has urged CMS to provide extra motivation for plans to comply: Mandate that plans approve any prior authorization request that doesn't receive a response within the required time frame.

5. It's Time to Think Big When It Comes to Admin Burden in Medicare

Perhaps feeling like it's on a roll, CMS is asking whether it should create prior authorization rules for Medicare fee-for-service plans similar to what's currently proposed. While it's never a bad idea to evaluate the appropriateness of prior authorization, the fact is that most PTs don't face prior authorization requirements under Medicare FFS. Gilliard sees that an opportunity for the profession.

"The conversation about prior authorization in Medicare is an excellent way for APTA and the profession to open up a bigger dialogue about administrative burden in all its forms," Gilliard said. "For PTs, prior authorization isn't the biggest challenge in traditional Medicare part B — it's the plan-of-care certification requirements. If CMS wants to look at prior authorization because it sees value in reducing administrative burden, this is another area worth looking at."

APTA's comment tip: Tell CMS that you appreciate that the agency wants to make Medicare FFS less burdensome, but suggest that the agency broaden its focus.

Read Full Article

 

Remote Therapeutic Monitoring: APTA Updates

While it's been more than a year since PTs were included in the list of providers able to bill for several remote therapeutic monitoring codes under the Medicare Physician Fee Schedule, details continue to be worked out — and possible changes discussed. APTA pursues those details and remains at the table for important conversations around what may or may not happen next.

Here's the latest on the PT's use of RTM under the fee schedule.

We've Updated the APTA Practice Advisory on RTM
In response to questions from members, APTA added more information to the practice advisory we published soon after the U.S. Centers for Medicare & Medicaid Services announced it would extend use of two sets of CPT codes related to RTM for use by PTs. The new information provides additional insight on billing requirements and PTA supervision.

We're Advocating for Continued Patient Access to RTM by PTs
APTA staff and member representatives participated in a recent Medicare Contractor Advisory Committee meeting to discuss the application of remote therapeutic monitoring in physical therapist practice. Generally speaking, these committee meetings are intended to be a platform for communication between providers and Medicare contractors; the Feb. 28 meeting was focused on soliciting input from subject matter experts about the use of physiologic monitoring and RTM. The aim of the meeting: To find out if it would be a good idea to establish a local coverage determination for these services. APTA made the case for no LCD, with our representatives sharing the association’s position that an LCD could interfere with patient access to these important services. APTA will submit comments as a follow-up to the call.

We're Working to Clear up Confusion Among MACs Around RTM Codes
APTA is communicating with Medicare Administrative Contractors — aka MACs — to address an apparent error in claims processing related to denials of services that should be covered. Specifically, since Jan. 1, 2023, when facilities have submitted claims for RTM on a UB-04 claim form, the MACs have accepted claims for codes 98975, 98976, and 98977 but denied codes 98980 and 98981, asserting that they're non-covered services. This is incorrect. APTA reached out to the MACs and is working with a representative from the Critical Inquiries Unit to address the error. APTA staff will provide updates as available.

 
<< first < Prev 11 12 13 14 15 16 17 18 19 20 Next > last >>

Page 16 of 172